2015
DOI: 10.1016/j.jinorgbio.2015.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Nitric oxide- and cisplatin-releasing silica nanoparticles for use against non-small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
41
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 68 publications
(43 citation statements)
references
References 75 publications
0
41
0
Order By: Relevance
“…Such a result will support the idea that induction of a potent anti-tumoral response against NPC may rely in part on the induction of (NO) • synthesis. In case of verification of our hypotheses, future interventional and clinical approaches should take into account the possibility of manipulating the nitrosative stress in-vivo, by directly delivering (NO) • or NOS2 substrate bearing molecules, such as nanoparticles, to the tumor site or to (NO) • producing cells, to increase nitric oxide bioavailability and possibly inhibit NPC metastatic activity and induce tumor cell clearance [62, 63]. …”
Section: Discussionmentioning
confidence: 99%
“…Such a result will support the idea that induction of a potent anti-tumoral response against NPC may rely in part on the induction of (NO) • synthesis. In case of verification of our hypotheses, future interventional and clinical approaches should take into account the possibility of manipulating the nitrosative stress in-vivo, by directly delivering (NO) • or NOS2 substrate bearing molecules, such as nanoparticles, to the tumor site or to (NO) • producing cells, to increase nitric oxide bioavailability and possibly inhibit NPC metastatic activity and induce tumor cell clearance [62, 63]. …”
Section: Discussionmentioning
confidence: 99%
“…It is noteworthy that the additive cytotoxic effects of NO did not significantly affect normal cells (H9c2 rat cardiomyoblast), implying that the potential applications of combined NO and drug delivery are conducive for tumor cell selective therapy. Balkus Jr. et al employed a similar strategy in the synthesis of a silica based nanoparticle formulation [68]. They prepared amine-modified mesoporous silica nanoparticles (MSN), followed by loading of cisplatin and modification with diazeniumdiolate.…”
Section: Progress Of Combined No and Drug Delivery Systemsmentioning
confidence: 99%
“…In addition, the ability of the combined NO and drug delivery systems in overcoming MDR can be exhibited after their efficient accumulation at the target sites. The combined NO and drug delivery systems are expected to provide a solution to resolve this problem because NO has potential in increasing tumor perfusion, which can improve the enhanced permeation and retention (EPR) effect that allows macromolecules to penetrate leaky tumor blood vessels surrounding solid tumor [68,79]. In conclusion, the continuing endeavor to surmount these challenges will pave the way for achieving clinical applications of the combined NO and drug delivery system to enhance chemotherapy.…”
Section: Conclusion and Perspectivementioning
confidence: 99%
“…Huang et al used mesoporous silica nanoparticles as carriers with a high density of carboxylic groups inside their mesopores to load hydrophilic Pt II drugs through chelation . A similar strategy has been followed by Lv et al who tested mercaptopurine‐modified mesoporous silica nanoparticles as nanocarriers of cisplatin, and by Balkus and co‐workers who designed nitric‐oxide‐ and cisplatin‐releasing wrinkle‐structured amine‐modified mesoporous silica nanoparticles . A more sophisticated system has been published by Mohapatra et al who synthesized hollow mesoporous silica nanospheres; the exterior was selectively functionalized with carboxylic groups to conjugate cisplatin, folic acid and rhodamine isothiocyanate, whereas the interior space was used to encapsulate superparamagnetic nanoparticles as well as the hydrophobic anticancer drug pemetrexed .…”
Section: Introductionmentioning
confidence: 99%